Saimah Nasir

Q: What is Saimah Nasir email address?

Email Saimah Nasir at saimahnasir@hotmail.com and saimah.nasir@iconplc.com. This email is the most updated Saimah Nasir's email found in 2026.

Q: How to contact Saimah Nasir?

To contact Saimah Nasir send an email to saimahnasir@hotmail.com or saimah.nasir@iconplc.com. (updated on September 29, 2024)

Study Manager at Merck-Innovative Strategies through ICON at ICON plc | Greater Toronto Area, Canada

About Saimah Nasir

Saimah Nasir is a seasoned clinical research professional with over 14 years of extensive experience in both quantitative and qualitative research within the realm of clinical trials. Currently serving as a Study Manager at ICON plc, specifically on assignment with Merck's Innovative Strategies team, Saimah plays a pivotal role in driving global clinical trial operations. Her expertise spans various therapeutic areas, with a particular focus on oncology, where she has successfully managed complex studies that adhere to stringent FDA regulations and compliance standards.

In her current role, Saimah is instrumental in overseeing the development and execution of clinical trial protocols, ensuring that they align with both regulatory requirements and the strategic objectives of Merck. Her proficiency in Clinical Trial Management Systems (CTMS) and Clinical Data Management enables her to streamline processes, enhance data integrity, and facilitate effective communication across multidisciplinary teams. Saimah's strong interpersonal communication skills allow her to foster collaborative relationships with stakeholders, including regulatory affairs teams, healthcare professionals, and study participants, ensuring that all aspects of trial management are executed seamlessly.

Key projects under her leadership have included the implementation of innovative strategies that enhance patient recruitment and retention, ultimately leading to improved trial outcomes. Saimah’s commitment to excellence in clinical research, combined with her in-depth knowledge of Standard Operating Procedures (SOPs) and regulatory frameworks, positions her as a vital asset in advancing Merck's mission to deliver groundbreaking therapies to patients worldwide. Her dedication to the pharmaceutical industry and her strategic insights continue to drive impactful results in the ever-evolving landscape of clinical research.

Saimah Nasir Work